NEW YORK (GenomeWeb News) – Protea Biosciences and Gelcompany, a wholly owned subsidiary of Australian firm Fluorotechnics, today said that they will collaborate on developing new technology for improved protein analysis.
Under the agreement, Protea has the right to distribute certain Gelcompany products in the North American life sciences market. The companies also said that they intend to collaborate on the co-development of new protein separation products for the global life sciences market.
"The addition of these products gives Protea a full line of superior gel-based protein separation products," Reid Asbury, director of sales and marketing for Morgantown, WV-based Protea Biosciences said in a statement. "We will be capable of addressing the entire market from sample preparation to mass spectrometry."
Terms of the agreement were not disclosed.